Contemporary approaches to perioperative management of coronary stents and to preoperative coronary revascularization: A survey of 374 interventional cardiologists

Cardiovascular Revascularization Medicine

Volumn 12, Issue 2, 2011, Pages 99-104

  Khair, Tarif ^a   Garcia, Bobby ^a   Banerjee, Subhash ^a   Brilakis, Emmanouil S ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Complications; Coronary revascularization; Noncardiac surgery; Stents

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST;

ARTICLE; CARDIOLOGIST; COMBINATION CHEMOTHERAPY; CORONARY STENT; DRUG ELUTING STENT; HEART MUSCLE REVASCULARIZATION; HUMAN; PATIENT SELECTION; PEROPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; QUESTIONNAIRE; TREATMENT INDICATION;

CARDIOLOGY; DRUG-ELUTING STENTS; HEALTH CARE SURVEYS; HEMORRHAGE; HUMANS; METALS; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; PROSTHESIS DESIGN; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; STENTS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 79952732109     PISSN: 15538389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carrev.2009.09.007     Document Type: Article

References (24)

1. Brilakis E, Banerjee S, Berger P Perioperative management of coronary stents. J Am Coll Cardiol 2007, 49:2145-2150.
2. Layland J, Jellis C, Whitbourn R Extremely late drug-eluting stent thrombosis: 2037 days after deployment. Cardiovasc Revasc Med 2009, 10(1):55-57.
3. Varghese I, Ummer A, Roesle M, Banerjee S, Brilakis ES Recurrent late drug-eluting stent thrombosis upon discontinuation of antiplatelet therapy. Cardiovasc Revasc Med 2008, 9(3):179-181.
4. Compton PA, Zankar AA, Adesanya AO, Banerjee S, Brilakis ES Risk of noncardiac surgery after coronary drug-eluting stent implantation. Am J Cardiol 2006, 98(9):1212-1213.
5. Schouten O, van Domburg RT, Bax JJ, de Jaegere PJ, Dunkelgrun M, Feringa HHH, Hoeks SE, Poldermans D. Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events. J Am Coll Cardiol 2007, 49(1):122-124.
6. Brotman DJ, Bakhru M, Saber W, Aneja A, Bhatt DL, Tillan-Martinez K, Jaffer AK Discontinuation of antiplatelet therapy prior to low-risk noncardiac surgery in patients with drug-eluting stents: a retrospective cohort study. J Hosp Med 2007, 2(6):378-384.
7. Kim HL, Park KW, Kwak JJ, Kim YS, Sir JJ, Lee SJ, Lee HY, Chang HJ, Kang HJ, Cho YS, et al. Stent-related cardiac events after non-cardiac surgery: drug-eluting stent vs. bare metal stent. Int J Cardiol 2008, 123(3):353-354.
8. Godet G, Le Manach Y, Lesache F, Perbet S, Coriat P Drug-eluting stent thrombosis in patients undergoing non-cardiac surgery: is it always a problem?. Br J Anaesth 2008, 100(4):472-477.
9. Rhee SJ, Yun KH, Lee SR, Chae JK, Nam CW, Jun DH, Jeong JW Drug-eluting stent thrombosis during perioperative period. Int Heart J 2008, 49(2):135-142.
10. Rabbitts JA, Nuttall GA, Brown MJ, Hanson AC, Oliver WC, Holmes DR, Rihal CS Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology 2008, 109(4):596-604.
11. Kaluza GL, Joseph J, Lee JR, Raizner ME, Raizner AE Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000, 35(5):1288-1294.
12. Wilson SH, Fasseas P, Orford JL, Lennon RJ, Horlocker T, Charnoff NE, Melby S, Berger PB Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 2003, 42(2):234-240.
13. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol 2007, 50(17):e159-e241.
14. Grines CL, Bonow RO, Casey DE, Gardner TJ, Lockhart PB, Moliterno DJ, O'Gara P, Whitlow P Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol 2007, 49(6):734-739.
15. Brilakis ES, Orford JL, Fasseas P, Wilson SH, Melby S, Lennon RJ, Berger PB Outcome of patients undergoing balloon angioplasty in the two months prior to noncardiac surgery. Am J Cardiol 2005, 96(4):512-514.
16. Keeley EC, Boura JA, Grines CL Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003, 361(9351):13-20.
17. Brilakis ES, Banerjee S, Berger PB The risk of drug-eluting stent thrombosis with noncardiac surgery. Curr Cardiol Rep 2007, 9(5):406-411.
18. D'Urbano M, Barlocco F, Poli A, Fetiveau R, Vandoni P, Savonitto S, De Servi S Unplanned surgery after drug eluting stent implantation: a strategy for safe temporary withdrawal of dual oral antiplatelet therapy. J Cardiovasc Med 2008, 9(7):737-741.
19. Broad L, Lee T, Conroy M, Bolsin S, Orford N, Black A, Birdsey G Successful management of patients with a drug-eluting coronary stent presenting for elective, non-cardiac surgery. Br J Anaesth 2007, 98(1):19-22.
20. Jaffe R, Halon DA, Carmeli J, Lewis BS Prolonged intravenous eptifibatide infusion for prevention of coronary stent thrombosis. Int J Cardiol 2007, 114:409-411.
21. Augoustides JG Perioperative thrombotic risk of coronary artery stents: possible role for intravenous platelet blockade. Anesthesiology 2007, 107(3):516.
22. McFalls EO, Ward HB, Moritz TE, Goldman S, Krupski WC, Littooy F, Pierpont G, Santilli S, Rapp J, Hattler B, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004, 351(27):2795-2804.
23. Patterson L, Hunter D, Mann A Appropriate waiting time for noncardiac surgery following coronary stent insertion: views of Canadian anesthesiologists. Can J Anaesth 2005, 52(4):440-441.
24. Lozano I, Martin D, Torres F, Avanzas P, Rondan J, Garcia-Ruiz JM, Hernandez E, Bayon J, Vegas JM, Espolita A Knowledge of coronary stents, thrombosis and dual antiplatelet therapy among Spanish dentists. Rev Esp Cardiol 2009, 62(2):153-157.